Cargando…

North American cost analysis of brand name versus generic drugs for the treatment of glaucoma

BACKGROUND: According to the World Health Organization, glaucoma is a leading cause of irreversible blindness worldwide. By 2020, 80 million people will be affected by glaucoma in the world, which represents a significant financial burden to society. Glaucoma medications alone make up 38–52% of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malvankar-Mehta, Monali S, Feng, Lucy, Hutnik, Cindy ML
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924989/ https://www.ncbi.nlm.nih.gov/pubmed/31908505 http://dx.doi.org/10.2147/CEOR.S156558

Ejemplares similares

Generics versus brand-named drugs for glaucoma: the debate continues
por: Bhartiya, Shibal, et al.
Publicado: (2020)

Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023)

Prevalence of Obstructive Sleep Apnea in Glaucoma Patients: A Systematic Review and Meta-analysis
por: Yu, Brian E, et al.
Publicado: (2021)

Generic versus brand-name drugs used in cardiovascular diseases
por: Manzoli, Lamberto, et al.
Publicado: (2015)

The Effectiveness of Teleglaucoma versus In-Patient Examination for Glaucoma Screening: A Systematic Review and Meta-Analysis
por: Thomas, Sera-Melisa, et al.
Publicado: (2014)

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)

When Is Evidence Enough Evidence? A Systematic Review and Meta-Analysis of the Trabectome as a Solo Procedure in Patients with Primary Open-Angle Glaucoma
por: Chow, Jeffrey T. Y., et al.
Publicado: (2017)

What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice
por: Steinman, Michael A., et al.
Publicado: (2007)

The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis
por: Kiatos, Efstathia, et al.
Publicado: (2017)

iStent with Phacoemulsification versus Phacoemulsification Alone for Patients with Glaucoma and Cataract: A Meta-Analysis
por: Malvankar-Mehta, Monali S., et al.
Publicado: (2015)

Impact of Ophthalmic Viscosurgical Devices in Cataract Surgery
por: Malvankar-Mehta, Monali S., et al.
Publicado: (2020)

iStent as a Solo Procedure for Glaucoma Patients: A Systematic Review and Meta-Analysis
por: Malvankar-Mehta, Monali S., et al.
Publicado: (2015)

Elemental impurities analysis in name-brand and generic omeprazole drug samples
por: Pinheiro, Fernanda C., et al.
Publicado: (2020)

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
por: Sarpatwari, Ameet, et al.
Publicado: (2016)

Comparative efficacy of generic nifedipine versus brand‐name amlodipine for hypertension management in Taiwan
por: Lee, Hao‐Wei, et al.
Publicado: (2022)

Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2017)

Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
por: Yang, Ping, et al.
Publicado: (2021)

Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis
por: Diaconita, Vlad, et al.
Publicado: (2018)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
por: Tang, L., et al.
Publicado: (2018)

Generic versus brand-name over-the-counter analgesics: knowledge and attitudes among Swedish pharmacy customers
por: Håkonsen, Helle, et al.
Publicado: (2020)

Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia
por: Ordóñez, Karen, et al.
Publicado: (2019)

Scholarly Impact of Academic Ophthalmologists and Vision Scientists in Canada
por: Kryshtalskyj, Michael T, et al.
Publicado: (2021)

Comparison of the Effects of a Brand-name Drug and Its Generic Drug on the Quality of Life of Alzheimer’s Disease Patients
por: Sakakibara, Mikio, et al.
Publicado: (2015)

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
por: Ochi, Nobuaki, et al.
Publicado: (2014)

Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review
por: van der Meersch, Amélie, et al.
Publicado: (2011)

Brand-name drug, generic drug, orphan drug. Pharmacological therapy with biosimilar drugs – provision of due diligence in the treatment process
por: Zajdel, Justyna, et al.
Publicado: (2013)

Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2015)

Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels
por: Brito, Juan P., et al.
Publicado: (2020)

Distribution and trends in outpatient utilization of generic versus brand name psychopharmaceuticals during a ten-year period in Croatia
por: Polić-Vižintin, Marina, et al.
Publicado: (2014)

Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs
por: Ito, Yuki, et al.
Publicado: (2019)

Appearances of Premature Atrial and Ventricular Contractions After Switching From Brand Name to Generic Cibenzoline
por: Oguri, Gaku, et al.
Publicado: (2023)

The Cost-Effectiveness Analysis of Teleglaucoma Screening Device
por: Thomas, Sera, et al.
Publicado: (2015)

Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data
por: Farfan-Portet, Maria-Isabel, et al.
Publicado: (2012)

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
por: Desai, Rishi J, et al.
Publicado: (2018)

Repeat Selective Laser Trabeculoplasty for Glaucoma Patients: A Systematic Review and Meta-analysis
por: Jang, Hyunsoo J, et al.
Publicado: (2021)

Generic atorvastatin is as effective as the brand-name drug (LIPITOR(®)) in lowering cholesterol levels: a cross-sectional retrospective cohort study
por: Loch, Alexander, et al.
Publicado: (2017)

Evaluation of blood pressure lowering effect by generic and brand-name antihypertensive drugs treatment: a multicenter prospective study in China
por: Zhang, Shu-Yuan, et al.
Publicado: (2021)

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
por: Rome, Benjamin N., et al.
Publicado: (2021)

Effect of Generic vs. Brand-Name Meropenem on Mortality in a Colombian Hospital’s Intensive Care Unit
por: Feinstein, Max, et al.
Publicado: (2017)

Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018
por: Lin, Shuo-yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v2vqodeshoa2cvjhdlhmf62nto